Momentum Bioscience Limited

Sepsis is the leading cause of hospital death with ~700K EU deaths annually. To treat a sepsis infection, we must identify the causative pathogens and determine their antibiotic susceptibility. However, existing blood culture testing is slow (days) and sepsis kills quickly (hours). Clinicians therefore initiate treatment with broad-spectrum antibiotics. T...

Momentum Bioscience was founded to develop rapid tests for clinical specimens within the hospital microbiology laboratory, supporting the global fight against antibiotic resistance and the need for improved antimicrobial stewardship. Sepsis (blood poisoning) kills more people than bowel, breast and prostate cancer combined but symptoms of sepsis are frequ...

Sepsis (blood poisoning) now kills more people in the UK than lung cancer. Symptoms of sepsis can often be confused with other problems such as fever caused by cancer therapy. Because it still takes up to five days to diagnose sepsis in the hospital laboratory, patients at risk are put on expensive front-line antibiotics until the lab gives a result. This...

The Company has developed a test allowing the hospital microbiology laboratory to rapidly detect bacterial and fungal infections in blood. Current methods usually take 1-3 days to tell if a blood specimen is positive and 5 days to report if it is negative. The new test provides both positive and negative results in 24 hours which helps to save hospital co...

Awaiting Public Project Summary